Relmada Therapeutics Inc Q3 2022 Earnings Call Transcript - Thomson StreetEvents

Relmada Therapeutics Inc Q3 2022 Earnings Call Transcript

Relmada Therapeutics Inc Q3 2022 Earnings Call Transcript - Thomson StreetEvents
Relmada Therapeutics Inc Q3 2022 Earnings Call Transcript
Published Nov 10, 2022
14 pages (7793 words) — Published Nov 10, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of RLMD.OQ earnings conference call or presentation 10-Nov-22 9:30pm GMT

  
Brief Excerpt:

...Operator Good afternoon. My name is Kathy, and I'll be your conference operator for today. At this time, I would like to welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2022 Earnings Call. (Operator Instructions) And Brian Ritchie, you may begin your conference. >>Brian Ritchie - LifeSci Advisors, LLC Thank you, operator, and thank you all for joining us this afternoon. With me on today's call are Chief Executive Officer, Sergio Traversa; and Chief Financial Officer, Maged Shenouda. This afternoon, Romana issued a news release providing a business update announcing financial results for the 3 and 9 months ended September 30, 2022, and filed its quarterly report on Form 10-Q with the SEC. Please note that certain information discussed on the call today is covered under the safe harbor provisions of the Private Securities Litigation Reform Act. We caution listeners during this call that Relmada's management team will be making forward-looking statements. Actual results could...

  
Report Type:

Transcript

Source:
Company:
Relmada Therapeutics Inc
Ticker
RLMD.OQ
Time
9:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Relmada Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript – 2023-06-14 – US$ 54.00 – Edited Transcript of RLMD.OQ presentation 14-Jun-23 10:20pm GMT

Relmada Therapeutics Inc at Jefferies Healthcare Conference Transcript – 2023-06-08 – US$ 54.00 – Edited Transcript of RLMD.OQ presentation 8-Jun-23 7:00pm GMT

Relmada Therapeutics Inc Q1 2023 Earnings Call Transcript – 2023-05-11 – US$ 54.00 – Edited Transcript of RLMD.OQ earnings conference call or presentation 11-May-23 8:30pm GMT

Relmada Therapeutics Inc Q4 2022 Earnings Call Transcript – 2023-03-23 – US$ 54.00 – Edited Transcript of RLMD.OQ earnings conference call or presentation 23-Mar-23 8:30pm GMT

Relmada Therapeutics Inc Top-line Results from Phase 3 RELIANCE I Trial for REL-1017 as an Adjunctive Treatment for Major Depressive Disorder - Corporate Call Transcript – 2022-12-07 – US$ 54.00 – Edited Transcript of RLMD.OQ conference call or presentation 7-Dec-22 10:00pm GMT

Relmada Therapeutics Inc Q2 2022 Earnings Call Transcript – 2022-08-11 – US$ 54.00 – Edited Transcript of RLMD.OQ earnings conference call or presentation 11-Aug-22 8:30pm GMT

Relmada Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript – 2022-06-14 – US$ 54.00 – Edited Transcript of RLMD.OQ presentation 14-Jun-22 5:40pm GMT

Relmada Therapeutics Inc Q1 2022 Earnings Call Transcript – 2022-05-05 – US$ 54.00 – Edited Transcript of RLMD.OQ earnings conference call or presentation 5-May-22 8:30pm GMT

Relmada Therapeutics Inc Q4 2021 Earnings Call Transcript – 2022-03-23 – US$ 54.00 – Edited Transcript of RLMD.OQ earnings conference call or presentation 23-Mar-22 8:30pm GMT

Relmada Therapeutics Inc Results of Human Abuse Potential Study of REL-1017 vs. Ketamine - Corporate Call Transcript – 2022-02-23 – US$ 54.00 – Edited Transcript of RLMD.OQ conference call or presentation 23-Feb-22 1:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Relmada Therapeutics Inc Q3 2022 Earnings Call Transcript" Nov 10, 2022. Alacra Store. May 13, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2022-Relmada-Therapeutics-Inc-Earnings-Call-T15389064>
  
APA:
Thomson StreetEvents. (2022). Relmada Therapeutics Inc Q3 2022 Earnings Call Transcript Nov 10, 2022. New York, NY: Alacra Store. Retrieved May 13, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2022-Relmada-Therapeutics-Inc-Earnings-Call-T15389064>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.